6533b839fe1ef96bd12a59bd

RESEARCH PRODUCT

High prevalence of SARS-CoV-2 antibodies in pets from COVID-19+ households

Eric M. LeroyVincent LegrosVincent LegrosPierre BecquartMatthieu FritzBéatrice RosolenMeriadeg Ar GouilhOxana VratskikhSolène DenollyEric ElgueroEmilie KrafftBertrand BosonAngeli KodjoCatherine ChirouzeJessica VanhomwegenSerge G. Rosolen

subject

0303 health sciencesHigh prevalenceCATSbiologyCoronavirus disease 2019 (COVID-19)040301 veterinary sciencesbusiness.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)04 agricultural and veterinary sciences3. Good health0403 veterinary science03 medical and health sciencesEnvironmental healthbiology.proteinMedicineSeroprevalenceAntibodybusiness030304 developmental biology

description

AbstractIn a survey of household cats and dogs of laboratory-confirmed COVID-19 patients, we found a high seroprevalence of SARS-CoV-2 antibodies, ranging from 21% to 53%, depending on the positivity criteria chosen. Seropositivity was significantly greater among pets from COVID-19+ households compared to those with owners of unknown status. Our results highlight the potential role of pets in the spread of the epidemic.

yearjournalcountryeditionlanguage
2020-09-22
https://doi.org/10.1101/2020.09.22.307751